Physiologic Effects of Nasal High Flow on Exercise Tolerance in COPD
Part of paid clinical trials in Miami, Florida.
- Sponsor
- University of Miami
- Study ID
- NCT06578156
- Status
- Recruiting
Conditions
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - 100 Years
- Healthy Volunteers
- Not accepted
Interventions
- Nasal High Flow Cannula — DEVICEHigh flow nasal cannula is a device that provides heated and humidified high flow gases. In-person. Depending on participant's availability, up to 6 times
- Nasal Low Flow Cannula — DEVICELow flow nasal cannula is a device that provides low flow gases. In-person. Depending on participant's availability, up to 6 times
Study Details
This study aims to assess whether to describe the effects of the administration of nasal high flow (NHF) at 70 liters per minute (L/min) in a 6-Minute Walk Test (6-MWT) among Chronic Obstructive Pulmonary Disease (COPD) patients and to characterize the association between self-reported dyspnea with and without NHF at 70 L/min following a 6-MWT.
Key Dates
- Start date
- Dec 12, 2024
- Status verified
- Apr 2026
- Primary completion
- Dec 31, 2027
- Completion
- Dec 31, 2027
Study Design
- Enrollment
- 30 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- CROSSOVER
- Primary purpose
- TREATMENT
Arms
- Experimental: Nasal High Flow CannulaNasal High Flow cannula at 70 liters per minute for 30 minutes. Given that this is a cross-over study, participants on this arm will be then crossed over to Nasal Low Flow Cannula at less than or equal to 4 liters per minute with supplemental oxygen for 30 minutes
- Active Comparator: Nasal Low Flow CannulaLow Flow Nasal Cannula at less than or equal to 4 liters per minute with supplemental oxygen at patient's baseline for 30 minutes. Given that this is a cross-over study, participants on this arm will be then crossed over to High Flow Cannula at 70 liters per minute for 30 minutes
Primary Outcome Measure
6-minute walk test [ Time Frame: 30 minutes ]
Central Contacts
- Saramaria Afanador Castiblanco, M.D.305-243-2568
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| University of Miami | Miami | Florida | 33136 | Saramaria Afanador Castiblanco, M.D. (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Miami, FL
By condition
By specialty
By research site
Related Studies
- Global Utilization And Registry Database for Improved preservAtion of doNor LUNGsEnrolling By Invitation · Paragonix Technologies · Phoenix, Arizona
- myAirvo 3 (High Flow Nasal Therapy; HFNT) for COPD Patients in the HomeRecruiting · Temple University · Birmingham, Alabama
- A Study to Evaluate Solrikitug in Participants With COPD (ZION)PHASE2 · Recruiting · Uniquity One (UNI) · Birmingham, Alabama
- Bronchoscopic RElease of Air Trapped in Hyperinflated Emphysematous Lung - Study 3Recruiting · Apreo Health, Inc. · Birmingham, Alabama